|
|
Blood, Vol. 112, Issue 7, 2687-2693, October 1, 2008
Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo–purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group
Blood Geisler et al.
112: 2687
Supplemental materials for: Geisler et al
The following members and centres of Nordic Lymphoma Group contributed with patients to this trial: Denmark:
Christian Geisler, Niels Andersen, Dept. of Hematology Rigshospitalet, Copenhagen
Anne Marie Boesen, Dept. of Hematology Århus University Hospital
Lars Møller Pedersen, Per Boye Hansen, Dept. of Hematology Herlev University Hospital Finland:
Erkki Elonen, Dept. of Hematology Helsinki University Central Hospital
Outi Kuittinen, Dept. of Oncology, Oulu University Hospital Norway:
Arne Kolstad, Grethe F. Lauritzsen, Dept. of Oncology, The Norwegian Radium Hospital, Oslo
Bjørn Østenstad, Dept. of Oncology, Ullevaal University Hospital: Roald Ekanger, Dept. of Oncology, Haukeland University Hospital, Bergen
Martin Maisenhølder, Dept. of Oncology, Tromsø University Hospital
Unn-Merete Fagerli, Dept. of Oncology, Trondheim University Hospital Sweden:
Hans Bäck, Dept. of Medicine, Borås Hospital
Herman Nilsson-Ehle, Göran Nilsson, Dept. of Hematology, Sahlgrenska University Hospital, Gothenburg
Eva Kimby, Marie Nordström, Dept. of Hematology, Karolinska Institute, Stockholm
Anders Lindblom, Dept. of Hematology, Malmö University General Hospital
Susanne Fredén, Dept. of Oncology, Jönköping Hospital
Lena Malmberg, Dept. of Oncology, Karlstad Hospital
Martin Hjorth, Dept. of Medicine, Lidköping Hospital
Mats Jerkeman, Mikael Eriksson, Dept. of Oncology, Lund University Hospital
Franz Rommel, Dept. of Hematology, Norrköping Hospital
Jaan Väärt, Dept. of Medicine, Skövde Hospital
Beatrice Malmér, Dept. of Oncology, Umeå University Hospital, Anna Laurell, Dept. of Oncology, Academic Hospital, Uppsala
Johan Vaktnäs, Dept. of Medicine, Varberg Hospital
|
|
